China Drug Administration Proposes Pharmaceutical Data Protection Guidelines

Published date29 May 2018
Law FirmKnobbe Martens
AuthorJane Dai, Ph.D.,Raj Pai, PhD.
Subject MatterData Protection,China,Applications,Clinical Trials,Public Comment,Drug Safety,Orphan Drugs,Draft Guidance,Drug Pricing,Public Information,Pharmaceutical Industry,Marketing Exclusivity Periods,Food and Drug Administrations

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT